Catalent leads a fragmented nutraceutical contract manufacturing market

The nutraceutical contract manufacturing services market remains highly fragmented, with the top 10 players holding just 9% of revenue in 2024, according to The Business Research Company. Catalent Inc. led global sales with a 2% share as manufacturers race to add capacity, expand dosage formats, and sharpen compliance and formulation capabilities.

Why it matters: - The market is being shaped by rising demand for outsourced production of dietary supplements, functional nutrition products, and wellness brands. - Competitive advantage now hinges on formulation depth, regulatory compliance, ingredient sourcing, and the ability to scale across multiple dosage formats. - Market fragmentation leaves room for specialists, but also raises the bar for operational execution and supply chain reliability.

What happened: - The Business Research Company released its Nutraceutical Contract Manufacturing Services Global Market Report 2026, covering market size, trends, and forecasts for 2026-2035. - Catalent Inc. led global sales in 2024 with a 2% market share. - The top 10 players accounted for 9% of total market revenue in 2024. - The report said the market is fragmented and includes contract development and manufacturing organizations, nutraceutical formulation specialists, and integrated health product manufacturing providers.

The details: - Catalent’s consumer health and nutraceutical manufacturing business spans formulation development, encapsulation, tableting, softgel manufacturing, packaging, and supply chain services. - The company’s portfolio supports product innovation, manufacturing flexibility, quality assurance, and faster commercialization across supplements and wellness products. - Other leading companies by market share include Lonza Group AG, Royal DSM, Glanbia Plc, and Ashland Global Holdings Inc., each listed at 1% to 2%. - Smaller named players include Robinson Pharma Inc. at 0.1%, Gemini Pharmaceuticals Inc. at 0.04%, Martínez Nieto at 0.03%, NutraScience Labs at 0.01%, and Menadiona at 0.01%. - Major raw material suppliers include Archer-Daniels-Midland, Kerry Group, Ingredion, Givaudan, International Flavors & Fragrances, Kemin Industries, Glanbia Nutritionals, Prinova Group, Roquette Frères, and DSM-Firmenich. - Major wholesalers and distributors include Univar Solutions, Brenntag, IMCD, Barentz, DKSH, Azelis, Helm, Biesterfeld, LBB Specialties, and Aceto Corporation. - Major end users include Herbalife, Amway, Abbott Laboratories, Haleon, Jamieson Wellness, USANA Health Sciences, NOW Foods, Pharmavite, Bayer Consumer Health, and Unilever. - The report also listed recent analytical upgrades for its 2026 market reports, including market attractiveness scoring, TAM analysis, company scoring matrices, Excel forecasting dashboards, market hotspot infographics, and updated graphics and tables.

Between the lines: - Capacity expansion is becoming a key competitive lever as manufacturers try to shorten lead times and serve more product formats. - In April 2025, Robinson Pharma announced an expansion that added 10 softgel machines, new tablet and capsule production lines, a high-throughput liquid supplement system, and a dedicated pectin gummy facility. - The emphasis on gummies, clean-label ingredients, automation, and customized nutrition points to a market moving toward more differentiated consumer products rather than generic bulk production. - The concentration data suggests scale matters, but no single player dominates the category.

What's next: - Manufacturers are expected to keep investing in automation, capacity expansion, and strategic partnerships to protect share and speed commercialization. - Growth opportunities appear strongest in advanced delivery formats, personalized nutrition, and flexible outsourced production. - The report says these shifts should strengthen the competitive position of firms that can combine scale with formulation expertise.

The bottom line: - Nutraceutical contract manufacturing is a low-concentration market where capacity, compliance, and customization are now the main differentiators.